Affimed Therapeutics completes IPO

Affimed Therapeutics N.V. (NASDAQ:AFMD), Heidelberg, Germany Business: Cancer, Inflammation, Antibodies Date completed: 2014-09-12 Type: IPO Raised: $56 million Shares: 8 million Price: $7 Shares afte...